A new pancreatic cancer drug has been described as the "closest thing to a cure" after a clinical trial.
Drachonresib made headlines in May after it was found to nearly double the survival time for patients compared to chemotherapy alone.
A new pancreatic cancer drug has been described as the "closest thing to a cure" after a clinical trial.
Drachonresib made headlines in May after it was found to nearly double the survival time for patients compared to chemotherapy alone.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in